A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Decisions of Herantis Pharma Plc's Annual General Meeting of shareholders

Decisions of Herantis Pharma Plc's Annual General Meeting of shareholders Herantis Pharma Plc Company release 11 April 2016 at 5:00…

Read More

Herantis Pharma receives orphan designation of CDNF for treatment of ALS

Herantis Pharma receives orphan designation of CDNF for treatment of ALS Herantis Pharma Plc Company release 29 March 2016 at…

Read More

Herantis Pharma's Annual Report 2015 published

Herantis Pharma's Annual Report 2015 published Herantis Pharma Plc Company release 17 March 2016 at 10:00 am Herantis Pharma Plc's…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.